Anivive
Anivive Lifesciences is an animal health company focused on addressing unmet medical needs in pets through a combination of artificial intelligence, biotech, and veterinary medicine. They utilize proprietary software and predictive analytics to accelerate the discovery, development, and commercialization of new and affordable treatments for a range of conditions including cancers, fungal diseases, and viral infections. The company is actively developing a Valley Fever vaccine for dogs, a treatment for Feline Infectious Peritonitis (FIP), and a canine cancer therapeutic, among others. Anivive aims to provide more treatment options for the 85% of pet diseases that currently lack approved therapies, with a stated goal of giving pets more time and improving their health.
Anivive
Anivive Lifesciences is an animal health company focused on addressing unmet medical needs in pets through a combination of artificial intelligence, biotech, and veterinary medicine. They utilize proprietary software and predictive analytics to accelerate the discovery, development, and commercialization of new and affordable treatments for a range of conditions including cancers, fungal diseases, and viral infections. The company is actively developing a Valley Fever vaccine for dogs, a treatment for Feline Infectious Peritonitis (FIP), and a canine cancer therapeutic, among others. Anivive aims to provide more treatment options for the 85% of pet diseases that currently lack approved therapies, with a stated goal of giving pets more time and improving their health.